News item
AHPRA launches new guidance in peptide prescribing crackdown
Amid warnings that ‘reckless’ prescribing jeopardises clinicians’ right to practise, it’s released practical guidance and case studies for prescribing off-label and unapproved medicines.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.